MedPath

Emergency Ventilator Splitting Between Two or More Patients (COVID-19)

Not Applicable
Withdrawn
Conditions
COVID-19
Interventions
Device: Emergency Ventilator Splitter
Registration Number
NCT04381013
Lead Sponsor
Stanford University
Brief Summary

The purpose of this study is to develop a safe, easily scalable, and simple method to split a single ventilator for use amongst two or more patients, thus serving as a capacity bridge to save patient lives until manufacturers can produce enough ventilators.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Phase I

    • Undergoing routine thoracic surgery which will include the use of a dual lumen endotracheal tube at Stanford.
  • Phase II

    • Able to give consent
    • On venovenous extracorporeal membrane oxygenation for reason other than COVID-19
  • Phase III

    • Able to give consent
    • Infected with COVID-19 and will likely require mechanical ventilation.
Read More
Exclusion Criteria
  • Phase I

    • Significant cardiac comorbidities
    • Liver disease
  • Phase II

    • Significant cardiac comorbidities
    • Pre or Post-transplant patient
    • Infection with COVID-19
  • Phase III

    • Co-infection with disease aside from COVID-19
    • Severely ill requiring high ventilator requirements and not stable for ventilator splitting
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Phase 2: ECHO treatmentEmergency Ventilator SplitterDuring care with Extracorporeal Membrane Oxygenation (ECMO) for non-SARS-CoV-2, endotracheal tubes split from ventilator delivering oxygen independently to each lung for up to 24 hours.
Phase 1: Routine surgeryEmergency Ventilator SplitterAs part of routine cardio-thoracic surgery, endotracheal tubes split from ventilator delivering oxygen independently to each lung for up to 1 minute.
Phase 3: COVID-19 treatmentEmergency Ventilator SplitterEndotracheal tubes split from ventilator delivering oxygen independently to two patients with COVID-19 disease for up to 1 hour.
Primary Outcome Measures
NameTimeMethod
Completion of 24-hour testUp to 1 hour

This outcome will measure whether the device will function for respiratory support for 1 hour (yes or no; phase 3 only)

Completion of 1-minute testUp to 1 minute

This outcome will measure whether the device will function for respiratory support for 1 minute (yes or no; phase 1 only)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Stanford University

πŸ‡ΊπŸ‡Έ

Stanford, California, United States

Β© Copyright 2025. All Rights Reserved by MedPath